Long-acting combination of cabotegravir plus rilpivirine: a picture of potential eligible HIV-positive individuals from the Italian ARCA cohort

被引：0
|
作者：
Cervo, A. [1 ]
Russo, A. [2 ]
Di Carlo, D. [3 ]
De Vito, A. [4 ]
Fabeni, L. [5 ]
D'Anna, S. [6 ]
Duca, L. [6 ]
Colpani, A.
Fois, M.
Zauli, B.
Mancarella, G. [7 ]
Carraro, A. [7 ]
Bezenchek, A. [8 ]
Cozzi-Lepri, A. [9 ]
Santoro, M. [6 ]
机构：
[1] Univ Hosp Modena, Infect Dis Clin, Modena, Italy
[2] Univ Campania Luigi Vanvitelli, Dept Mental Hlth, Infect Dis Unit, Naples, Italy
[3] Univ Milan, Dept Biomed Clin Sci L Sacco, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, Milan, Italy
[4] Univ Sassari, Dept Med Surg & Expt Sci, Unit Infect Dis, Sassari, Italy
[5] L Spallanzani Natl Inst Infect Dis, Rome, Italy
[6] Tor Vergata Univ Rome, Rome, Italy
[7] Sapienza Univ Rome Polo Pontino, Unit Infect Dis, Latina, Italy
[8] InformaPRO SRL, EuResist Network GEIE, Rome, Italy
[9] Inst Global Hlth, Ctr Clin Res Epidemiol Modelling & Evaluat, London, England
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P096
引用
收藏
页码：95 / 97
页数：3
相关论文
共 50 条
  • [21] Compassionate use of long-acting cabotegravir plus rilpivirine for people living with HIV-1 in need of parenteral antiretroviral therapy
    D'Amico, Ronald
    Gomis, Santiago Cenoz
    Moodley, Riya
    Van Solingen-Ristea, Rodica
    Baugh, Bryan
    Van Landuyt, Erika
    Van Eygen, Veerle
    Min, Sherene
    Cutrell, Amy
    Foster, Caroline
    Chilton, Daniella
    Allard, Sabine D.
    Ruiter, Annemiek
    HIV MEDICINE, 2023, 24 (02) : 202 - 211
  • [22] COST-EFFECTIVENESS OF CABOTEGRAVIR (CAB) plus RILPIVIRINE (RPV) LONG-ACTING (LA) IN PEOPLE LIVING WITH HIV (PLHIV) IN AUSTRIA
    Uhl, G.
    Schroeder, M.
    VALUE IN HEALTH, 2022, 25 (12) : S125 - S125
  • [23] Direct switch from an efavirenz-based regimen to intramuscular long-acting cabotegravir plus rilpivirine: A case report
    Senkoro, Elizabeth
    Bracchi, Margherita
    Heskin, Joseph
    Walters, Yasmin
    Varadarajan, Maithili
    Antoniadi, Christina
    Al-Shakarchi, Yaser
    Girometti, Nicolo
    Boffito, Marta
    INTERNATIONAL JOURNAL OF STD & AIDS, 2024, 35 (04) : 311 - 313
  • [24] Impact of Switching to Long-Acting Injectable Cabotegravir Plus Rilpivirine on Rectal HIV-1 RNA Shedding and Implications for Transmission Risk
    Masia, Mar
    Fernandez-Gonzalez, Marta
    Ledesma, Christian
    Losada-Echeberria, Maria
    Gonzalo-Jimenez, Nieves
    Mascarell, Paula
    Garcia-Abellan, Javier
    Lopez, Leandro
    Bello-Perez, Melissa
    Padilla, Sergio
    Gutierrez, Felix
    JOURNAL OF INFECTIOUS DISEASES, 2025,
  • [25] The potential role of long-acting injectable cabotegravir-rilpivirine in the treatment of HIV in sub-Saharan Africa: a modelling analysis
    Phillips, Andrew N.
    Bansi-Matharu, Loveleen
    Cambiano, Valentina
    Ehrenkranz, Peter
    Serenata, Celicia
    Venter, Francois
    Pett, Sarah
    Flexner, Charles
    Jahn, Andreas
    Revill, Paul
    Garnett, Geoff P.
    LANCET GLOBAL HEALTH, 2021, 9 (05): : E620 - E627
  • [26] Preference-based measure of health from participants in Phase 3 studies of long-acting cabotegravir and rilpivirine for the treatment of HIV
    Wu, Sterling
    Jacob, Ian
    Van de Velde, Nicolas
    Chounta, Vasiliki
    HIV MEDICINE, 2021, 22 : 73 - 73
  • [27] Long-Acting Injectable Cabotegravir plus Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials
    Rizzardini, Giuliano
    Overton, Edgar T.
    Orkin, Chloe
    Swindells, Susan
    Arasteh, Keikawus
    Gorgolas Hernandez-Mora, Miguel
    Pokrovsky, Vadim
    Girard, Pierre-Marie
    Oka, Shinichi
    Andrade-Villanueva, Jaime F.
    Richmond, Gary J.
    Baumgarten, Axel
    Masia, Mar
    Latiff, Gulam
    Griffith, Sandy
    Harrington, Conn M.
    Hudson, Krischan J.
    St Clair, Marty
    Talarico, Christine L.
    Patel, Parul
    Cutrell, Amy
    Van Eygen, Veerle
    D'Amico, Ronald
    Mrus, Joseph M.
    Wu, Sterling
    Ford, Susan L.
    Chow, Ken
    Roberts, Jeremy
    Wills, Angela
    Walters, Nicola
    Vanveggel, Simon
    Van Solingen-Ristea, Rodica
    Crauwels, Herta
    Smith, Kimberly Y.
    Spreen, William R.
    Margolis, David A.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2020, 85 (04) : 498 - 506
  • [28] Cost-effectiveness of the long-acting regimen cabotegravir plus rilpivirine for the treatment of HIV-1 and its potential impact on adherence and viral transmission: A modelling study
    Parker, Ben
    Ward, Tom
    Hayward, Olivia
    Jacob, Ian
    Arthurs, Erin
    Becker, Debbie
    Anderson, Sarah-Jane
    Chounta, Vasiliki
    Van de Velde, Nicolas
    PLOS ONE, 2021, 16 (02):
  • [29] Injectable Long-Acting Cabotegravir-Rilpivirine Therapy for People Living With HIV/AIDS: Addressing Implementation Barriers From the Start
    Pinto, Rogerio M.
    Hall, Evan
    Tomlin, Ryan
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2023, 34 (02): : 216 - 220
  • [30] Learning From Full Characterization of HIV Proviruses in People Receiving Long-Acting Cabotegravir/Rilpivirine With a History of Replication on the Antiretroviral Classes
    Mchantaf, Gilbert
    Chaillon, Antoine
    Charre, Caroline
    Melard, Adeline
    Gardiennet, Elise
    Guinard, Jerome
    Prazuck, Thierry
    Guillaume, Clemence
    Mariaggi, Alice-Andree
    Bois, Julie
    Hocqueloux, Laurent
    Avettand-Fenoel, Veronique
    OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (01):
12345